In 2006, however, The Stroke Prevention by Aggressive Reaction in Cholesterol Levels (SPARCL) study raised concerns over a small increase in the incidence of haemorrhagic stroke with statin therapy.
The findings were then once again echoed in a 2007 study, which found stroke survivors who took high doses of atorvastatin appeared to be at an increased risk of stroke from bleeding in the brain.
But the authors stressed that the drug was a less significant risk factor for haemorrhagic stroke than having uncontrolled high blood pressure.
“Although low serum cholesterol levels have been associated with an increased incidence of hemorrhagic stroke, a large prospective meta-analysis including more than 90,000 patients, who mostly had no history of stroke or transient ischaemic attacks, showed no increase in haemorrhagic stroke occurrence.
Source: | This article first appeared on Express.co.uk
Original Article
